Clover Health is trading at $5.03, up 9.83% in pre-market after its PPO Medicare Advantage plans received a 5-Star CMS rating for 2027.

  • Its HMO plan received 4.5 Stars; the company says the PPO rating enables year-round enrollment and affects the 2028 payment year.
  • News coverage tied the after-hours jump to the CMS ratings release, reporting shares up 8.5% after-hours.
  • The five-star PPO result was calculated without 20 disputed measures; including them, the rating would have been 4.5 Stars.